Literature DB >> 9387797

Autonomic dysfunction in Parkinson's disease.

Y Koike1, A Takahashi.   

Abstract

This article is a review of autonomic dysfunction in idiopathic Parkinson's disease (iPD), as well as the clinical features of a specific form of PD, i.e. autonomic failure (AF) with PD, and is based mainly on the results obtained from our recent studies. Since James Parkinson's original discription, the definition of autonomic dysfunctions in iPD and their clinical characteristics have undergone changes. Autonomic dysfunction is considered to be uncommon and rarely severe on one hand, while not infrequent but not as severe as in Shy-Drager syndrome on the other hand. AF with PD is characterized by severe orthostatic hypotension, postprandial hypotension, supersensitivity to noradrenaline, low or absent uptake of m-[123I]iodobenzylguanidine scintigraphy of the limbs, and preserved arginine vasopressin response to head-up tilt, suggesting a postganglionic sympathetic lesion resembling pure AF (PAF). On the other hand, reduced cortical glucose metabolism in positron emission tomography study may indicate that AF with PD has diffuse nervous system lesions resembling diffuse Lewy body disease.

Entities:  

Mesh:

Year:  1997        PMID: 9387797     DOI: 10.1159/000113470

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  8 in total

1.  Clinical and physiological characteristics of autonomic failure with Parkinson's disease.

Authors:  Y Niimi; T Ieda; M Hirayama; Y Koike; G Sobue; Y Hasegawa; A Takahashi
Journal:  Clin Auton Res       Date:  1999-06       Impact factor: 4.435

2.  Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Authors:  Thomas G Beach; Charles H Adler; Geidy Serrano; Lucia I Sue; D G Walker; Brittany N Dugger; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Anthony Intorcia; Jessica Filon; Sarah Scott; Angelica Garcia; Brittany Hoffman; Christine M Belden; Kathryn J Davis; Marwan N Sabbagh
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

3.  (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.

Authors:  S Orimo; E Ozawa; S Nakade; T Sugimoto; H Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

4.  Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Linda Vedders; Lihfen Lue; Charles L White Iii; Haru Akiyama; John N Caviness; Holly A Shill; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2010-03-21       Impact factor: 17.088

5.  Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease.

Authors:  K Hamada; M Hirayama; H Watanabe; R Kobayashi; H Ito; T Ieda; Y Koike; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

6.  Consequences of dopaminergic denervation on the metabolic activity of the cortical neurons projecting to the subthalamic nucleus in the rat.

Authors:  Gaël Orieux; Chantal François; Jean Féger; Etienne C Hirsch
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

Review 7.  (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review.

Authors:  Eun Joo Chung; Sang Jin Kim
Journal:  J Mov Disord       Date:  2015-05-31

Review 8.  Sleep and circadian rhythms in Parkinson's disease and preclinical models.

Authors:  Jeremy Hunt; Elizabeth J Coulson; Rajendram Rajnarayanan; Henrik Oster; Aleksandar Videnovic; Oliver Rawashdeh
Journal:  Mol Neurodegener       Date:  2022-01-09       Impact factor: 14.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.